ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260743.1	ABT-263 (navitoclax)	Chronic Lymphocytic Leukemia	0.02222717	Resistant
ENSG00000260743.1	ABT-263 (navitoclax)	Brain lower grade glioma	0.037005743	Sensitive